Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review

E-ISSN： 1365-2362|45|5|475-484

ISSN： 0014-2972

Source： EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol.45, Iss.5, 2015-05, pp. : 475-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neighborhood deprivation and cardiovascular disease risk factors: Protective and harmful effects

By Cubbin Catherine Sundquist Kristina Ahlén Helena Johansson Sven Winkleby Marilyn Sundquist Jan

Scandinavian Journal of Public Health, Vol. 34, Iss. 3, 2006-06 ,pp. : 228-237

Informa Healthcare

Access to resources Recommend Favorite

Systematic review and network meta‐analysis on the relative efficacy of osteoporotic medications: men with prostate cancer on continuous androgen‐deprivation therapy to reduce risk of fragility fractures

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 17-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2713-2719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for cardiovascular disease: renewed interest in triglycerides

By Berglund Lars Sacks Frank Brunzell John D

Clinical Lipidology, Vol. 8, Iss. 1, 2013-02 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite

Chronic kidney disease and end‐stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta‐analysis

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 9, 2015-09 ,pp. : 998-1006

John Wiley & Sons Inc

Access to resources Recommend Favorite